<?xml version='1.0' encoding='us-ascii' standalone='no'?>
<html xmlns='http://www.w3.org/1999/xhtml' xmlns:xbrli='http://www.xbrl.org/2003/instance' xmlns:dei='http://xbrl.sec.gov/dei/2021' xmlns:i='http://www.xbrl.org/2003/instance' xmlns:xbrldi='http://xbrl.org/2006/xbrldi' xmlns:iso4217='http://www.xbrl.org/2003/iso4217' xmlns:ix='http://www.xbrl.org/2013/inlineXBRL' xmlns:ixt='http://www.xbrl.org/inlineXBRL/transformation/2015-02-26' xmlns:ixt-sec='http://www.sec.gov/inlineXBRL/transformation/2015-08-31' xmlns:utr='http://www.xbrl.org/2009/utr' xmlns:link='http://www.xbrl.org/2003/linkbase' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance'>
<head>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2021 [PPW4SKFZFJ9YVF7FL2DN]. www.edgarsuite.com -->
<title>NUNZIA PHARMACEUTICAL COMPANY - Form 8-K SEC filing</title>
<meta content='text/html; charset=UTF-8' http-equiv='Content-Type' />
</head>
<body>
<div style='display:none'>
<ix:header>
<ix:hidden>
<ix:nonNumeric name='dei:EntityCentralIndexKey' contextRef='D210816' id='fact1'>0000886093</ix:nonNumeric>
<ix:nonNumeric name='dei:AmendmentFlag' contextRef='D210816' id='fact2'>false</ix:nonNumeric>
</ix:hidden>
<ix:references>
<link:schemaRef xlink:arcrole='http://www.xbrl.org/2003/linkbase' xlink:href='nunz-20210816.xsd' xlink:type='simple'/>
</ix:references>
<ix:resources>
<i:context id='D210816'>
<i:entity>
<i:identifier scheme='http://www.sec.gov/CIK'>0000886093</i:identifier>
</i:entity>
<i:period>
<i:startDate>2021-08-16</i:startDate>
<i:endDate>2021-08-16</i:endDate>
</i:period>
</i:context>
</ix:resources>
</ix:header>
</div>
<div><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'><b>UNITED STATES</b></p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'><b>SECURITIES AND EXCHANGE COMMISSION</b></p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'><b>WASHINGTON, D.C. 20549</b></p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'><b>FORM <ix:nonNumeric name='dei:DocumentType' contextRef='D210816' escape='true'>8-K</ix:nonNumeric></b></p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'><b>CURRENT REPORT</b></p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'><b>Pursuant to Section 13 or 15(d) of the</b></p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'><b>Securities Exchange Act of 1934</b></p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'><span style='border-bottom:1px solid #000000'><b>Date of Report: </b></span><ix:nonNumeric name='dei:DocumentPeriodEndDate' contextRef='D210816' format='ixt:datemonthdayyearen'>August 16, 2021</ix:nonNumeric></p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'><b>(Date of earliest event reported)</b></p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>Commission File Number: <ix:nonNumeric name='dei:EntityFileNumber' contextRef='D210816' escape='true'>001-39175</ix:nonNumeric></p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'><b><ix:nonNumeric name='dei:EntityRegistrantName' contextRef='D210816' escape='true'>NUNZIA PHARMACEUTICAL COMPANY</ix:nonNumeric></b></p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>(Exact name of registrant as specified in its charter)</p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<table style='margin:0 auto;border-collapse:collapse;width:100%'><tr><td valign='top' style='width:47.96%;padding-left:6pt;padding-right:6pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'><b><ix:nonNumeric name='dei:EntityIncorporationStateCountryCode' contextRef='D210816' format='ixt-sec:stateprovnameen'>Utah</ix:nonNumeric></b></p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>(State or other jurisdiction of incorporation or organization)</p>
</td><td valign='top' style='width:52.04%;padding-left:6pt;padding-right:6pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'><b><ix:nonNumeric name='dei:EntityTaxIdentificationNumber' contextRef='D210816' escape='true'>87-0442090</ix:nonNumeric></b></p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>(I.R.S. Employer Identification No.)</p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:47.96%;padding-left:6pt;padding-right:6pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'><ix:nonNumeric name='dei:EntityAddressAddressLine1' contextRef='D210816' escape='true'>1627 West 14th Street</ix:nonNumeric><b>, <ix:nonNumeric name='dei:EntityAddressCityOrTown' contextRef='D210816' escape='true'>Long Beach</ix:nonNumeric>, <ix:nonNumeric name='dei:EntityAddressStateOrProvince' contextRef='D210816' format='ixt-sec:stateprovnameen'>California</ix:nonNumeric></b></p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:52.04%;padding-left:6pt;padding-right:6pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'><b><ix:nonNumeric name='dei:EntityAddressPostalZipCode' contextRef='D210816' escape='true'>90813</ix:nonNumeric></b></p>
</td></tr>
<tr><td valign='top' style='width:47.96%;padding-left:6pt;padding-right:6pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'>(Address of principal executive offices)</p>
</td><td valign='top' style='width:52.04%;padding-left:6pt;padding-right:6pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'>(Zip Code)</p>
</td></tr>
</table>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'><span style='border-bottom:1px solid #000000'><b><ix:nonNumeric name='dei:CityAreaCode' contextRef='D210816' escape='true'>(714)</ix:nonNumeric></b><b> </b><b><ix:nonNumeric name='dei:LocalPhoneNumber' contextRef='D210816' escape='true'>609 9117</ix:nonNumeric></b></span></p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>(Registrant&#8217;s telephone number, including area code)</p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'><b>N/A</b></p>
<table style='margin:0 auto;border-collapse:collapse;width:100%'><tr><td valign='top' style='background-color:#FFFFFF;width:100%;padding-left:5.4pt;padding-right:5.4pt;border-top:1pt solid #000000'><p style='font:10pt Times New Roman;margin:0;text-align:center'>(Former name, former address and former fiscal year)</p>
</td></tr>
</table>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:justify'>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>
<p style='font:10pt Times New Roman;margin:0;text-indent:36pt;text-align:justify'>&#160;</p>
<table style='margin:0 auto;border-collapse:collapse;width:100%'><tr><td valign='top' style='width:3.16%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
</td><td valign='top' style='width:3.16%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'><ix:nonNumeric name='dei:WrittenCommunications' contextRef='D210816' format='ixt-sec:boolballotbox'>&#9744;</ix:nonNumeric></p>
</td><td valign='top' style='width:93.66%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>
</td></tr>
<tr><td valign='top' style='width:3.16%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
</td><td valign='top' style='width:3.16%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'><ix:nonNumeric name='dei:SolicitingMaterial' contextRef='D210816' format='ixt-sec:boolballotbox'>&#9744;</ix:nonNumeric></p>
</td><td valign='top' style='width:93.66%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>
</td></tr>
<tr><td valign='top' style='width:3.16%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
</td><td valign='top' style='width:3.16%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'><ix:nonNumeric name='dei:PreCommencementTenderOffer' contextRef='D210816' format='ixt-sec:boolballotbox'>&#9744;</ix:nonNumeric></p>
</td><td valign='top' style='width:93.66%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>
</td></tr>
<tr><td valign='top' style='width:3.16%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
</td><td valign='top' style='width:3.16%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'><ix:nonNumeric name='dei:PreCommencementIssuerTenderOffer' contextRef='D210816' format='ixt-sec:boolballotbox'>&#9744;</ix:nonNumeric></p>
</td><td valign='top' style='width:93.66%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>
</td></tr>
</table>
<p style='font:10pt Times New Roman;margin:0'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:justify'>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>
<p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:justify'>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric name='dei:EntityEmergingGrowthCompany' contextRef='D210816' format='ixt-sec:boolballotbox'>&#9744;</ix:nonNumeric></p>
<hr style='border:0;height:0;width:0;margin:14pt 0 0 0'/><p style='font:10pt Times New Roman;margin:0;text-align:center'>1</p>
<hr style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'/><p style='line-height:0;margin:0'></p>
<p style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0'>Section 1 - Registrant&#8217;s Business and Operations <br/></p>
<p style='font:10pt Times New Roman;margin:0'>Item 1.01 Entry into a Material Definitive Agreement. </p>
<p style='font:10pt Times New Roman;margin:0'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0'>On June 9, 2021 GoCloud through there JV Partnership with the suppliers and authorized distributor issued an email authorizing NUNZIA Pharmaceutical to sell the following vaccines: J&amp;J, AZ, Pfizer, Moderna and Sputnick. </p>
<p style='font:10pt Times New Roman;margin:0'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0'>I have attached the email below.</p>
<hr style='border:0;height:0;width:0;margin:14pt 0 0 0'/><p style='font:10pt Times New Roman;margin:0;text-align:center'>2</p>
<hr style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'/><p style='line-height:0;margin:0'></p>
<p style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt'>&#160;</p>
<p style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:6pt;margin-right:18pt;text-align:justify'>&#160;</p>
<p style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:6pt;text-align:center'><b>SIGNATURES</b></p>
<p style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:6pt;text-align:justify'>Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>
<table style='margin:0 auto;border-collapse:collapse;width:100%'><tr><td colspan='2' valign='top' style='width:53.16%;padding-right:1.8pt'><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0'><b>NUNZIA PHARMACEUTICAL COMPANY</b></p>
</td><td valign='top' style='width:46.84%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:1.04%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
</td><td valign='top' style='width:52.12%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
</td><td valign='top' style='width:46.84%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:1.04%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
</td><td valign='top' style='width:52.12%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
</td><td valign='top' style='width:46.84%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
</td></tr>
<tr><td colspan='2' valign='top' style='width:53.16%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'>By: /<span style='border-bottom:1px solid #000000'>s/ Michael Mitsunaga</span></p>
</td><td valign='top' style='width:46.84%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
</td></tr>
<tr><td colspan='2' valign='top' style='width:53.16%;padding-left:18pt;padding-right:1.8pt'><p style='font:10pt Times New Roman;margin:0'>Michael Mitsunaga</p>
<p style='font:10pt Times New Roman;margin:0'>President</p>
</td><td valign='top' style='width:46.84%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
</td></tr>
<tr><td colspan='2' valign='top' style='width:53.16%;padding-left:18pt;padding-right:1.8pt'><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
</td><td valign='top' style='width:46.84%;padding-right:0.8pt'><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
</td></tr>
</table>
<p style='font:10pt Times New Roman;margin:0'>Dated: August 16, 2021</p>
<hr style='border:0;height:0;width:0;margin:14pt 0 0 0'/><p style='font:10pt Times New Roman;margin:0;text-align:center'>3</p>
<hr style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'/><p style='line-height:0;margin:0'></p>
<p style='font:10pt Times New Roman;margin-top:0pt;margin-bottom:8pt'>&#160;</p>
<p style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>&#160;</p>
<p style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt;text-align:center'><span style='border-bottom:1px solid #000000'><b>Exhibit</b></span></p>
<p style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt;text-align:center'>&#160;</p>
<table style='margin:0 auto;border-collapse:collapse'><tr><td valign='top' style='width:324.9pt'><p style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt'>Umashankar Das&#160;&lt;dr.udas999@gmail.com&gt;</p>
</td><td valign='top' style='width:153.9pt'><p style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt;text-align:right'>Jun 9, 2021, 3:41 PM</p>
</td></tr>
<tr><td valign='top' style='width:324.9pt'><p style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt;text-align:center'>&#160;</p>
</td><td valign='top' style='width:153.9pt'><p style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt;text-align:center'>&#160;</p>
</td></tr>
</table>
<p style='font:10pt Times New Roman;margin-top:6pt;margin-bottom:0pt;text-align:center'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0'>Hi Michael,</p>
<p style='font:10pt Times New Roman;margin:0'>It was nice talking to you. As discussed with you we have good access to covid vaccines through our JV partnership with the supplier and authorized distributor.&#160;Gocloud&#160;will sell to Nunzia the following vaccines: J&amp;J, AZ, Pfizer, Moderna and Sputnik.&#160;</p>
<p style='font:10pt Times New Roman;margin:0'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0'>Please let us know your requirements. We look forward to working with you to fulfil your orders.</p>
<p style='font:10pt Times New Roman;margin:0'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0'>Thank you.</p>
<p style='font:10pt Times New Roman;margin:0'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0'>Dr. Umashankar Das, Ph.D., M.B.A.</p>
<p style='font:10pt Times New Roman;margin:0'>President &amp; CEO</p>
<p style='font:10pt Times New Roman;margin:0'>Gocloud&#160;Technologies Inc.</p>
<hr style='border:0;height:0;width:0;margin:14pt 0 0 0'/><p style='font:10pt Times New Roman;margin:0;text-align:center'>4</p>
<p style='font:10pt Times New Roman;margin:0'>&#160;</p>
</div>
</body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "nunz-20210816.htm", "description": "NUNZIA PHARMACEUTICAL COMPANY - FORM 8-K SEC FILING", "secsgml_size_bytes": 18129}]
{"company-data": {"conformed-name": "NUNZIA PHARMACEUTICAL Co", "cik": "0000886093", "assigned-sic": "8741", "irs-number": "870442090", "state-of-incorporation": "UT", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-39175"}, "business-address": {"street1": "1627 WEST 14TH STREET", "city": "LONG BEACH", "state": "CA", "zip": "90813", "phone": "714-609-9117"}, "mail-address": {"street1": "1627 WEST 14TH STREET", "city": "LONG BEACH", "state": "CA", "zip": "90813"}, "former-company": [{"former-conformed-name": "Arizona Gold & Onyx Mining Co", "date-changed": "20100730"}, {"former-conformed-name": "VIKING CAPITAL GROUP INC", "date-changed": "19931102"}]}
NUNZIA PHARMACEUTICAL COMPANY - Form 8-K SEC filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report:
August 16, 2021
(Date of earliest event reported)
Commission File Number:
001-39175
NUNZIA PHARMACEUTICAL COMPANY
(Exact name of registrant as specified in its charter)
Utah
(State or other jurisdiction of incorporation or organization)
87-0442090
(I.R.S. Employer Identification No.)
1627 West 14th Street
,
Long Beach
,
California
90813
(Address of principal executive offices)
(Zip Code)
(714)
609 9117
(Registrant's telephone number, including area code)
N/A
(Former name, former address and former fiscal year)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
1
Section 1 - Registrant's Business and Operations
Item 1.01 Entry into a Material Definitive Agreement.
On June 9, 2021 GoCloud through there JV Partnership with the suppliers and authorized distributor issued an email authorizing NUNZIA Pharmaceutical to sell the following vaccines: J&J, AZ, Pfizer, Moderna and Sputnick.
I have attached the email below.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NUNZIA PHARMACEUTICAL COMPANY
By: /
s/ Michael Mitsunaga
Michael Mitsunaga
President
Dated: August 16, 2021
3
Exhibit
Umashankar Das <dr.udas999@gmail.com>
Jun 9, 2021, 3:41 PM
Hi Michael,
It was nice talking to you. As discussed with you we have good access to covid vaccines through our JV partnership with the supplier and authorized distributor. Gocloud will sell to Nunzia the following vaccines: J&J, AZ, Pfizer, Moderna and Sputnik.
Please let us know your requirements. We look forward to working with you to fulfil your orders.
Thank you.
Dr. Umashankar Das, Ph.D., M.B.A.
President & CEO
Gocloud Technologies Inc.
4